Covidien plc (COV) Introduces New Barrx RF Ablation Catheter for Treating Barrett's Esophagus
8/13/2013 9:50:36 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SUNNYVALE, Calif.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, announced the expansion of its portfolio of radiofrequency ablation (RFA) catheters with the launch of the Barrx™ Channel RFA Endoscopic Catheter for treating Barrett’s esophagus and certain gastrointestinal bleeding disorders1. Left untreated, Barrett’s esophagus, a precancerous condition of the esophageal lining, can lead to life-threatening cancer of the esophagus.
Help employers find you! Check out all the jobs and post your resume.
comments powered by